UAB 1428 – A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer (HOG Trial)

Grant

Date/time Interval

  • January 1, 2019 - December 31, 2020

    • Awarded By

    Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

    • Contributor

  • Ahmed Elkhanany   Investigator  
  • Erica Stringer-Reasor M.D.   Investigator  
  • Lisle Nabell M.D.   Principal Investigator